Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
15.75    0.00 (0.00%)
Bid:
15.50
Ask:
16.00
Spread: 0.50 (3.226%)
Market Cap: £13.00m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Half Year Results

3 Mar 2011 07:00

RNS Number : 2306C
Frontier IP Group plc
03 March 2011
Β 

ο»Ώ

FIPP

3 March 2011

Β 

Frontier IP Group Plc

("Frontier IP", "the Group" or "the Company")

Β 

Unaudited half year results to 31 December 2010

Β 

Frontier IP Group plc is focused on the commercialisation of university IP

Β 

Key Points

Β 

Β·; Encouraging results - benefiting from uplift in portfolio valuation

Β 

Β·; Total revenue of Β£296,000 (2009: 6 months Β£85,000)

Β 

Β·; Profit before tax of Β£69,000 (2009: 6 months loss Β£97,000)

Β 

Β·; Earnings per share of 1.39p (2009: 6 months loss per share 1.96p)*

Β 

Β·; Net assets per share as at 31 December 2010 of 50p (31 December 2009: 52p)*

Β 

Β·; Cash balances stood at Β£84,000 as at 31 December 2010 (2009: Β£469,000)

- raised Β£1 million (gross) in January 2011

Β 

Β·; Foundations for future growth in place:

- post the half year, successful admission to AIM and placing

- strong pipeline of opportunities to expand existing portfolio

- active discussions with additional university partners

Β 

Β·; Positive outlook

Β 

*Β Calculated using the consolidated number of issued ordinary shares of 10p each of 4,972,165 for all periods

Β 

Β 

Neil Crabb, Chairman of Frontier IP, said:

Β 

"Results for the six months to 31 December 2010 show excellent progress, with Frontier IP moving into profit for the first time. Our portfolio of spin-out companies continues to develop and we have seen an encouraging uplift in the valuation of our holdings.

Β 

The second half of the current financial year has started well, maintaining the progress achieved in the first half. On 31 January 2011, Frontier IP took a significant step forward with its admission to trading on AIM and at the same time, the completion of a placing to raise Β£1.0 million (gross) from a number of institutional shareholders.

Β 

The admission to AIM and placing will support the business as we seek to take advantage of the exciting opportunities available to the Group, both in terms of securing new long-term relationships and developing our existing portfolio. Β With the foundations for growth in place, the Board remains confident for the current year and beyond."

Β 

Β 

Β 

Β 

Enquiries

Β 

Frontier IP Group plc

Neil Crabb, Chairman

Β 

T: 0131 220 9491

Β 

Biddicks

Β 

Katie Tzouliadis / Sophie Lane

T: 020 3178 6378

Arbuthnot Securities Ltd

Tom Griffiths / Ed Groome

T: 020 7012 2000

Β 

Company website: www.frontierip.co.uk

Chairman's Statement

Β 

Introduction

Β 

I am pleased to present our first set of half year results since Frontier IP was admitted to trading on AIM at the end of January 2011. Results for the six months to 31 December 2010 show excellent progress in the first half, with the Group moving into profit for the first time. This performance was driven in particular by an IFRS uplift in the value of the portfolio and we continue to see good opportunities to expand our existing portfolio as we move through the second half. We have also moved discussions forward with a number of universities regarding potential new relationships during the first half and the pipeline for additional long-term partnerships remains strong.

Β 

Following the end of the first half, on 31 January 2011, Frontier IP took a significant step in its development by the admission of the Company's shares to trading on AIM and at the same time, undertaking a placing to raise Β£1.0 million (gross). The AIM quotation will assist the Company in its development and, with a strong financial platform in place to underpin the next growth phase, the Board views prospects very positively.

Β 

Results

Β 

Total revenue for the first half of the year was Β£296,000 (2009: Β£85,000), comprising anunrealised gain on the revaluation of investments of Β£218,000 (2009: unrealised loss Β£4,000) and revenue from services of Β£78,000 (2009: Β£89,000). Profit before tax was Β£69,000 (2009: loss Β£97,000) and earnings per share was 1.39p (2009: loss per share 1.96p).

Β 

Cash balances stood at Β£84,000 as at 31 December 2010 (2009: Β£469,000). Net assets per share as at 31 December 2010 were 50p (2009: 52p).

Β 

Following the end of the first half, there was a cash inflow of Β£1.0 million (gross) by way of a placing of 2,000,000 New Ordinary Shares at 50 pence per share completed on the Company's admission to AIM.

Β 

Business Model

Β 

The Frontier IP business model is low cost and offers the potential for high quality earnings and capital appreciation.

Β 

Our model is to forge close commercialisation relationships with universities and research institutions

whereby, as a result of the assistance provided to these organisations in the commercialisation of the IP produced from their research activities, Frontier IP seeks to share in the founder equity and licence revenue that these organisations receive from the commercialisation of this research. In addition, Frontier IP generates revenue from board retainers and fees for bespoke advisory work. Also, where appropriate, Frontier IP will establish a dedicated fund for each relationship. This will help to accelerate the commercialisation process and will also create recurring fund management income for the Group. Our intention is also to participate as a limited partner in these funds.

Β 

Our strategy is to grow the portfolio to build a strong foundation of commercialisation relationships, thereby generating value both from recurring revenue and from the capital appreciation of equity in spin-outs and of direct investment in the dedicated funds.

Β Β 

Operational Review

Β 

Frontier IP has taken a number of significant steps forward in its development since the start of the current financial year.

Β 

Our portfolio of spin-out companies continues to develop and we currently have interests in eight portfolio companies, compared to five at the same point last year. During the first half, we have seen an encouraging uplift in the valuation of our holdings in portfolio companies and we expect to make further progress in adding new companies to our portfolio going forward. We are seeking additional opportunities to expand our funds under management both with dedicated university funds and sector-specific funds, where appropriate.

Β 

The Group is in active discussions with a number of universities with a view to securing new relationships, which would provide the Group with a share of spin-out equity and licensing revenues on a long-term basis. In addition, Frontier IP intends, where appropriate, to establish dedicated funds for its new partner universities.

Β 

In September 2010, we strengthened the team with two senior appointments in order to take advantage of the growth opportunities available. Jackie McKay was appointed to the Board as Partnership Director and David Cairns was appointed to the Board as Executive Director. In addition, on admission to AIM, Michael Brennand was appointed Regional Director North West to assist the Group in its regional development. Their combined experience in IP commercialisation underpins our growth plans.

Β 

The admission to AIM at the end of January 2011 also assists the Company in its development going forward. The enhanced brand and market recognition should help us to secure additional long-term university partners as well as new limited partners for funds. The placing completed at the same time provides Frontier IP with the resources to support new commercialisation relationships, to support complementary advisory roles and capital commitments to new funds.

Β 

Outlook

Β 

We are continuing to build on the progress achieved in the first half. Whilst there is considerable disruption in the university sector arising from changes to funding arrangements and general pressure on budgets, demand for our services is increasing as these institutions seek to extract value from their intellectual property. Frontier IP is well placed to take advantage of these market opportunities. We also see the potential for consolidation within the university IP commercialisation sector and the Company's admission to AIM and accompanying placing underpin our aim to participate in this process.

Β 

With the foundations for growth in place, the Board remains confident for the current year and beyond and I look forward to updating shareholders as the year progresses.

Β 

Neil Crabb

Chairman

Β 

2 March 2011

Β 

Β 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

Β 

For the six months ended 31 December 2010

Β 

Β 

Β 

Β 

Β 

Notes

Six months ended31 December

2010 (unaudited)

Β Six months ended 31 December

2009 (unaudited)

Β 

Year ended

Β 30 June

2010 (audited)

Β 

Β£'000

Β£'000

Β£'000

Revenue

Β 

Β 

Β 

Β 

Revenue from services

Β 

78

89

142

Other operating income

Β 

Β 

Β 

Β 

Unrealised profit / (loss) on the revaluation of investments

Β 

218

(4)

(48)

Total revenue

Β 

296

85

94

Β 

Β 

Β 

Β 

Β 

Administrative expenses (net)

Β 

(227)

(184)

(422)

Β 

Β 

Β 

Β 

Β 

Profit / (loss) from operations

Β 

69

(99)

(328)

Β 

Β 

Β 

Β 

Β 

Finance income

Β 

-

2

2

Β 

Β 

Β 

Β 

Β 

Profit / (loss) before tax

Β 

69

(97)

(326)

Β 

Β 

Β 

Β 

Β 

Taxation

5

-

-

-

Β 

Β 

Β 

Β 

Β 

Profit / (loss) and total comprehensive income (expense) for the period

Β 

Β 

69

Β 

(97)

Β 

(326)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Earnings /(loss) per share attributable to the equity holders of the Company:

Β 

Β 

Β 

Β 

Basic earnings / (loss) per share

6

1.39p

(1.96p)

(6.56p)

Diluted earnings / ( loss) per share

6

1.39p

(1.96p)

(6.56p)

Β 

Β 

All of the Group's activities are classed as continuing and there were no comprehensive gains or losses in any period other than those included in the statement of comprehensive income.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

Β 

At 31 December 2010

Β As at 31 December

2010 (unaudited)

Β£'000

Β As at 31 December

2009 (unaudited)

Β£'000

As at

30 June

2010 (audited)

Β£'000

ASSETS

Β 

Β 

Β 

Non-current assets

Β 

Β 

Β 

Goodwill

1,966

1,966

1,966

Financial assets at fair value through profit and loss

461

149

179

2,427

2,115

2,145

Current assets

Trade receivables

Other current assets

Cash and cash equivalents

Β 

9

45

84

Β 

48

13

469

Β 

13

13

330

Β 

138

530

356

Total assets

2,565

2,645

2,501

Β 

LIABILITIES

Current liabilities

Trade and other payables

(101)

(54)

(107)

Β 

Net assets

Β 

2,464

Β 

2,591

Β 

2,394

Β 

Β 

EQUITY

Called up share capital

Share premium account

Reverse acquisition reserve

Share based payment reserve

Retained earnings

497

3,898

(1,667)

113

(377)

497

3,898

(1,667)

80

(217)

497

3,898

(1,667)

112

(446)

Β 

Total equity

Β 

2,464

Β 

2,591

Β 

2,394

Β 

Β 

Β 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Β 

For the six month period ended 31 December 2010

Β 

Β 

Β 

Β 

Share

Β capital

Β 

Β 

Share

premium

account

Β 

Β 

Reverse acquisition

Β reserve

Β 

Share-

based

payment

Β reserve

Β 

Β 

Profit

and loss

account

Β 

Β 

Β 

Β 

Total

Β 

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

At 1st July 2009

497

3,898

(1,667)

78

(120)

2,686

Loss for the period

-

-

-

-

(97)

(97)

Share-based payments

-

-

-

2

-

2

Β 

At 31 December 2009

497

3,898

(1,667)

80

(217)

2,591

Loss for the period

-

-

-

-

(229)

(229)

Share-based payments

-

-

-

32

-

32

At 30 June 2010

497

3,898

(1,667)

112

(446)

2,394

Profit for the period

-

-

-

-

69

69

Share-based payments

-

-

-

1

-

1

Β 

At 31 December 2010

497

3,898

(1,667)

113

(377)

2,464

Β 

Β 

Β 

Β 

Β 

CONSOLIDATED STATEMENT OF CASH FLOWS

Β 

For the six months ended 31 December 2010

Β 

Β 

Six months ended 31 December

2010 (unaudited)

Β£'000

Β 

Six months ended 31 December

2009 (unaudited)

Β£'000

Β 

Β 

Year ended 30 June

2010 (audited)

Β£'000

Cash flows from operating activities

Β 

Β 

Β 

Cash used in operations

(183)

(129)

(194)

Interest paid

-

-

-

Taxation paid

-

-

-

Net cash used in operating activities

(183)

(129)

(194)

Β 

Β 

Β 

Β 

Cash flows from investing activities

Β 

Β 

Β 

Purchase of financial assets at fair value through profit and loss

(63)

(114)

(188)

Interest received

-

2

2

Β 

Β 

Β 

Β 

Net cash used in investing activities

(63)

(112)

(186)

Β 

Β 

Β 

Β 

Net decrease in cash and cash equivalents

(246)

(241)

(380)

Β 

Β 

Β 

Β 

Cash and cash equivalents at beginning of period

330

710

710

Cash and cash equivalents at end of period

84

469

330

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash used in operations

Β 

Β 

Β 

Profit / (loss) before tax

69

(97)

(326)

Adjustments for share-based payments

1

2

34

Adjustment for finance income

-

(2)

(2)

Fair value (gain)/loss on financial assets at fair value through profit or loss

(218)

4

48

Changes in working capital:

Β 

Β 

Β 

Trade and other receivables

(28)

(44)

(9)

Trade and other payables

(7)

8

61

Β 

Β 

Β 

Β 

Β 

(183)

(129)

(194)

Β 

Β 

Β 

Β 

Β 

NOTES

Β 

Β 

1. General information

The Company is a limited liability company incorporated in England and with its registered office at NorthWest Wing, Bush House, Aldwych, London WC2B 4EZ. The Company's trading office is situated at 41 Charlotte Square, Edinburgh EH2 4HQ.

Β 

The Company is quoted on AIM after successful admission on 31 January 2011. Prior to this the company was quoted on the PLUS market.

Β 

This condensed consolidated interim financial information was approved and authorised for issue by a duly appointed and authorised committee of the Board of Directors on 2 March 2011.

Β 

2. Basis of preparation

This condensed consolidated interim financial information for the six months ended 31 December 2010 has been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting". The condensed consolidated interim financial information should be read in conjunction with the annual financial statements for the year ended 30 June 2010, which have been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the EU.

Β 

This condensed consolidated interim financial information does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006. The comparatives for the full year ended 30 June 2010 are not the Company's full statutory accounts for that year. A copy of the statutory accounts for that year has been delivered to the Registrar of Companies. The auditor's report on those accounts was unqualified and did not contain a statement under sections 498(2) or 498(3) of the Companies Act 2006.

3. Accounting policies

The accounting policies applied are consistent with those of the annual financial statements for the year ended 30 June 2010 as described in the Group's Annual Report for that year and as available on our website www.frontierip.co.uk.

Β 

Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings.

Β 

4. Segmental information

The chief operating decision-maker has been identified as the Group board of directors. The board reviews the Group's internal reporting in order to assess performance and allocate resources. Currently the Group has one operating activity, the commercialisation of University IP. All of the Group's activities are carried out in the UK.

Β 

5. Taxation

There is no charge to taxation for the six months to 31 December 2010 (2009: Nil). Although the Group made a profit for the period, it made a taxable loss after adjustment for non-taxable income.

Β 

A deferred tax asset has not been recognised in respect of losses in view of the uncertainty as to the level of future taxable profits.

Β 

Β 

6. Earnings / (loss) per share

The calculation of the basic earnings/(loss) per share for the six months ended 31 December 2010 and 31 December 2009 and for the year ended 30 June 2010 is based on the profits/(losses) attributable to the shareholders of Frontier IP Group Plc in each period divided by the weighted average number of shares in issue during the period.

Β 

A resolution to consolidate the share capital of the Company by issuing one new Ordinary share of 10p each for every 100 Ordinary shares of 0.1p each was passed at the Company's Annual General Meeting on 6 December 2010. The earnings and loss per share have been calculated as though the consolidation occurred on 30 June 2009.

Β 

Β 

Β 

Profits/(losses) attributable to shareholders

Weighted average number of shares

Basic earnings/ (loss) per share

Β 

Β£'000

Number

Pence

Β 

Β 

Β 

Β 

Six months ended 31 December 2010

69

4,972,165

1.39

Six months ended 31 December 2009

(97)

4,972,165

(1.96)

Year ended 30 June 2010

(326)

4,972,165

(6.56)

Β 

No warrant or option is potentially dilutive as the average market price of the ordinary shares during the above periods was less than the exercise price of the warrants and options, hence basic and diluted loss per share are the same.

Β 

7. Copies of Half Yearly Report

Copies of this announcement are available on the Company's website, www.frontierip.co.uk, and copies of the Half Yearly Report will be sent to shareholders and will be available on the Company's website and on request from the Company's offices at 41 Charlotte Square, Edinburgh EH2 4HQ no later than 31 March 2011.

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR LLFSDVVIFIIL
Date   Source Headline
24th Sep 20255:12 pmRNSHolding(s) in Company
13th Jun 20257:00 amRNSStrategic partnership for Cambridge innovation hub
10th Jun 20257:00 amRNS-RAlusid signs international distribution agreement
6th May 20257:00 amRNS-RTVG's vaccine candidate enters animal trials
16th Apr 20257:00 amRNS-RSyva signs option to license agreement with TVG
2nd Apr 20254:47 pmRNSDirector/PDMR Shareholding
31st Mar 20251:02 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSUnaudited Half Year Results
24th Mar 20257:00 amRNSCamGraphIC secures €25 million in Series A funding
18th Mar 20257:00 amRNS-RPulsiv wins PSMA’s Global Energy Efficiency Award
25th Feb 20257:00 amRNS-RGraphEnergyTech collaboration & Innovate UK grant
18th Feb 20257:00 amRNS-RTopps Tiles launches Alusid’s Mas floor tiles
31st Dec 20241:30 pmRNSTotal Voting Rights
30th Dec 20249:56 amRNSHolding(s) in Company
20th Dec 20247:00 amRNSGrant of Options
19th Dec 20244:14 pmRNSResult of AGM
29th Nov 20245:00 pmRNSTotal Voting Rights
29th Nov 20241:36 pmRNSHolding(s) in Company
27th Nov 20247:00 amRNSPosting of Circular & Annual Report, & AGM Notice
26th Nov 20247:00 amRNSResult of Retail Offer
22nd Nov 20241:31 pmRNSResult of Placing and Subscription
22nd Nov 20248:12 amRNSRetail Offer by PrimaryBid
22nd Nov 20247:01 amRNSProposed Placing and Subscription
22nd Nov 20247:00 amRNSFinal results for the year ended 30 June 2024
29th Oct 20244:45 pmRNSHolding(s) in Company
11th Sep 202412:10 pmRNSHolding(s) in Company
7th Aug 20243:52 pmRNSHolding(s) in Company
6th Aug 20243:47 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSPortfolio – Cambridge Raman Imaging loan facility
19th Jun 20247:00 amRNSHolding(s) in Company
24th May 20247:00 amRNSTopps Group’s arm launches Alusid floor tile range
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.